Aptiv
Aptiv's revenue rose 3.5% to $20.4 billion in fiscal 2025. Its operating margin was 5.8%, down from 9.3% a year earlier. Free cash flow was $1.5 billion, down 5.4%. It paid out $397 million in dividends and buybacks, 26% of free cash flow. The diluted share count fell 14.0%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2025, earnings per share fell 18.2% a year and net income 20.2% a year, while buybacks cut the share count by 19%.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Aptiv yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Aptiv's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Aptiv's fiscal 2025 free cash flow of $1.5B, net cash of −$5.9B at December 31, 2025 and 221 million diluted shares, from its filings. The scenarios are fitted to Aptiv: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 5.3% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 12%: 11% for a cyclical or higher-risk business (Automotive Parts & Equipment), plus 1 point as a smaller company, worth $9.2B; the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $43.61
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Aptiv's earnings per share of $1.06 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 20.5×, the middle of Aptiv's own P/E today, its peers' median and its sector's median (its peers' median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 13%, 12% and 11%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $43.61
- Value at this multiple, against the last close
- —
- Aptiv's P/E at the last close
- 41.1×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| AptivAPTV | $43.61 | $1.06 | 41.1× |
| AdientADNT | $16.75 | $0.55 | 30.5× |
| BorgWarnerBWA | $55.12 | $2.03 | 27.2× |
| AutolivALV | $115.32 | $8.32 | 13.9× |
| LearLEA | $116.57 | $10.74 | 10.9× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 3.1 | 1.5 | 1.6 | 1.6 | 1.9 |
| Debt incl. finance leases | 4.1 | 6.6 | 6.3 | 9.0 | 7.7 |
| Net debt (negative means net cash) | 0.9 | 5.1 | 4.7 | 7.4 | 5.9 |
| Net debt to EBITDA | 0.5x | 2.5x | 1.9x | 2.6x | 2.7x |
| Debt to equity | 0.5x | 0.8x | 0.6x | 1.0x | 0.8x |
| Interest coverage | 7.9x | 5.8x | 5.5x | 5.5x | 3.3x |
| Current ratio | 2.0x | 1.6x | 1.7x | 1.5x | 1.7x |
| Quick ratio | 1.5x | 1.1x | 1.2x | 1.1x | 1.2x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, 4 insiders bought $8.9 million of Aptiv shares on the open market, and 4 insiders sold $4.0 million, all of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Hakan AgnevallDirector | Bought | 4,100 | $48.58 | $199,178 | Form 4 |
| Aug 11, 2026 | Sean O MahoneyDirector | Bought | 11,000 | $50.25 | $552,700 | Form 4 |
| Aug 10, 2026 | Kevin P ClarkChair and CEO, Director | Bought | 51,190 | $48.89 | $2.5 million | Form 4 |
| Aug 5, 2026 | Paul M MeisterDirector | Bought | 105,631 | $47.33 | $5.0 million | Form 4 |
| Jun 15, 2026 | Obed D. LouissaintEVP & Chief People Officer | Sold plan | 3,000 | $69.60 | $208,800 | Form 4 |
| Jun 3, 2026 | Katherine H RamundoEVP, CLO, CCO & Secretary | Sold plan | 2,000 | $78.30 | $156,600 | Form 4 |
| May 8, 2026 | Hakan AgnevallDirector | Bought | 6,100 | $57.73 | $352,153 | Form 4 |
| Jan 8, 2026 | Katherine H RamundoEVP, CLO, CCO & Secretary | Sold plan | 5,000 | $85.00 | $425,000 | Form 4 |
| Dec 12, 2025 | Varun LaroyiaEVP & Chief Financial Officer | Sold plan | 5,000 | $80.05 | $400,250 | Form 4 |
| Dec 12, 2025 | Hakan AgnevallDirector | Bought | 3,700 | $80.25 | $296,925 | Form 4 |
| Dec 5, 2025 | Sean O MahoneyDirector | Sold plan | 7,881 | $76.60 | $603,685 | Form 4 |
| Dec 4, 2025 | Varun LaroyiaEVP & Chief Financial Officer | Sold plan | 14,500 | $77.88 | $1.1 million | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Fail | Fail |
| Cash from operations exceeds net income | Fail | Pass | Pass |
| Debt fell relative to assets | Pass | Fail | Pass |
| Current ratio rose | Pass | Fail | Pass |
| Share count didn't rise | Fail | Pass | Pass |
| Gross margin rose | Pass | Pass | Pass |
| Revenue rose relative to assets | Fail | Fail | Pass |
| F-score | 6 of 9 | 5 of 9 | 8 of 9 |
| Accruals ratio | 4.5% | −2.8% | −8.6% |
Compare
Put Aptiv side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Aptiv | FY25 | 3.5% | 5.8% | 7.5% | 3.7% | 2.7x | 8 | |
| Lear | FY25 | −0.2% | 3.3% | 2.3% | 8.9% | 1.2x | 7 | Compare |
| Adient | FY25 | −1.0% | — | 1.4% | 2.0% | 3.4x | 5 | Compare |
| BorgWarner | FY25 | 1.6% | 3.7% | 8.2% | 4.6% | 1.3x | 7 | Compare |
| Autoliv | FY25 | 4.1% | 10.1% | 6.6% | 20.3% | 1.0x | 8 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 12.3 | 12.9 | 14.4 | 14.4 | 13.1 | 15.6 | 17.5 | 20.1 | 19.7 | 20.4 |
| Revenue growth | 13.0% | 5.0% | 12.0% | −0.5% | −9.0% | 19.5% | 12.0% | 14.7% | −1.7% | 3.5% |
| Gross profit | 2.7 | 2.6 | 2.7 | 2.6 | 1.9 | 2.4 | 2.6 | 3.4 | 3.7 | 3.9 |
| Research and development | 0.8 | 0.9 | 1.2 | 1.2 | 1.0 | 1.0 | 1.1 | 1.3 | 1.1 | 1.1 |
| Operating income | 1.5 | 1.4 | 1.5 | 1.3 | 2.1 | 1.2 | 1.3 | 1.6 | 1.8 | 1.2 |
| Net income | 1.3 | 1.4 | 1.1 | 1.0 | 1.8 | 0.6 | 0.6 | 2.9 | 1.8 | 0.2 |
| Diluted EPS (US$) | 4.59 | 5.06 | 4.02 | 3.85 | 6.66 | 1.94 | 1.96 | 10.39 | 6.96 | 0.75 |
| Diluted shares (millions) | 274 | 268 | 265 | 257 | 271 | 271 | 271 | 283 | 257 | 221 |
| Cash flow | ||||||||||
| Cash from operations | 1.9 | 1.5 | 1.6 | 1.6 | 1.4 | 1.2 | 1.3 | 1.9 | 2.4 | 2.2 |
| Capital expenditure | 0.7 | 0.7 | 0.8 | 0.8 | 0.6 | 0.6 | 0.8 | 0.9 | 0.8 | 0.7 |
| Free cash flow | 1.3 | 0.8 | 0.8 | 0.8 | 0.8 | 0.6 | 0.4 | 1.0 | 1.6 | 1.5 |
| Dividends paid | 0.3 | 0.3 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Share buybacks | 0.6 | 0.4 | 0.5 | 0.4 | 0.1 | 0.0 | 0.0 | 0.4 | 4.1 | 0.4 |
| Acquisitions | 0.0 | 0.3 | 1.2 | 0.3 | 0.0 | 0.1 | 4.3 | 0.1 | 0.0 | 0.0 |
| Stock-based compensation | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 0.7 | 1.6 | 0.6 | 0.4 | 2.8 | 3.1 | 1.5 | 1.6 | 1.6 | 1.9 |
| Debt incl. finance leases | 4.0 | 4.2 | 4.7 | 4.8 | 4.2 | 4.1 | 6.6 | 6.3 | 9.0 | 7.7 |
| Total assets | 12.3 | 12.2 | 12.5 | 13.5 | 17.5 | 18.0 | 21.9 | 24.4 | 23.5 | 23.4 |
| Total liabilities | 9.5 | 8.7 | 8.8 | 9.4 | 9.4 | 9.4 | 12.8 | 12.6 | 14.4 | 13.9 |
| Shareholders' equity | 2.4 | 3.3 | 3.5 | 3.8 | 7.9 | 8.3 | 8.8 | 11.5 | 8.8 | 9.2 |
| Margins and ratios | ||||||||||
| Gross margin | 22.4% | 20.3% | 18.9% | 18.4% | 14.8% | 15.6% | 15.1% | 17.1% | 18.8% | 19.1% |
| Operating margin | 12.5% | 11.0% | 10.2% | 8.9% | 16.2% | 7.6% | 7.2% | 7.8% | 9.3% | 5.8% |
| Net margin | 10.2% | 10.5% | 7.4% | 6.9% | 13.8% | 3.8% | 3.4% | 14.7% | 9.1% | 0.8% |
| Free cash flow margin | 10.5% | 6.0% | 5.4% | 5.9% | 6.3% | 3.9% | 2.4% | 4.9% | 8.2% | 7.5% |
| Return on capital | 20.7% | 19.3% | 17.3% | 14.0% | 23.2% | 11.2% | 9.4% | 10.2% | 10.1% | 3.7% |
| Return on equity | 54.0% | 47.5% | 31.6% | 27.2% | 30.8% | 7.3% | 6.9% | 28.9% | 17.6% | 1.8% |
| Return on assets | 10.4% | 11.1% | 8.7% | 7.6% | 11.7% | 3.3% | 3.0% | 12.7% | 7.5% | 0.7% |
| Net debt to EBITDA | 1.6x | 1.3x | 1.9x | 2.2x | 0.5x | 0.5x | 2.5x | 1.9x | 2.6x | 2.7x |